Exscientia
EXAI
Performance
About Exscientia
Exscientia is a technology-driven drug design and development company, committed to creating more effective medicines for patients, faster.
Recent News
The 5 Largest IPOs in Biopharma History
The Company that Built TikTok’s Algorithm Is Now Designing Drugs for Diseases Pharma Called Undruggable
Isomorphic Labs Pulls $2.1B Series B Led By Thrive With MGX, Temasek, And UK Sovereign AI Fund: What The Capital Stack, IsoDDE Engine, And Novartis/Lilly/J&J Partnerships Mean For Drug Discovery
The Stanford Professor Behind an FDA-Cleared Cardiac AI Wants $1 Billion for His Next Company
Inside Oxford’s Biotech Hub: A Scientific Powerhouse Situated in the U.K.’s Golden Triangle
Eli Lilly Inks $2.25 B AI‑driven Drug Discovery Pact with Profluent
Meet Dalton, a New AI-Powered Drug Discovery Platform
Recent Deals
No recent deals for this company.